| (€‘000) | For the year ended December 31, | |||||||||||
| 2017 | 2016 | 2015 | ||||||||||
|
Grant income (RCAs) |
824 | 2,704 | 578 | |||||||||
|
Grant income (other) |
56 | 124 | 412 | |||||||||
|
Remeasurement of RCAs |
396 | 2,154 | 1,036 | |||||||||
|
R&D Tax credit |
1,161 | — | — | |||||||||
|
Change in fair value Contingent consideration and other financial liabilities |
193 | — | — | |||||||||
|
Other |
— | — | (312 | ) | ||||||||
|
|
|
|
|
|
|
|||||||
|
Total Other Operating Income |
2,630 | 4,982 | 1,714 | |||||||||
|
|
|
|
|
|
|
|||||||
|
Change in fair value Contingent consideration and other financial liabilities |
— | (1,634 | ) | — | ||||||||
|
Remeasurement of RCAs |
— | — | (1,392 | ) | ||||||||
|
Other |
(41 | ) | (8 | ) | — | |||||||
|
Total Other Operating Expenses |
(41 | ) | (1,642 | ) | (1,392 | ) | ||||||
|
|
|
|
|
|
|
|||||||
|
Net Other Operating Income |
2,590 | 3,340 | 322 | |||||||||
|
|
|
|
|
|
|
|||||||